RenovoRx (RNXT) Cash from Operations (2024 - 2025)

RenovoRx's Cash from Operations history spans 2 years, with the latest figure at 2270000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 3.46% year-over-year to 2270000.0; the TTM value through Sep 2025 reached 10383000.0, changed N/A, while the annual FY2024 figure was 9125000.0, 11.05% up from the prior year.
  • Cash from Operations for Q3 2025 was 2270000.0 at RenovoRx, up from 2302000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2194000.0 in Q3 2024 and bottomed at 3381000.0 in Q1 2025.